Rexulti was authorized in 2018 for the therapy of schizophrenia in grownups.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/lundbeck-drug-receives-eu-approval-for-treatment-of-schizophrenia-in-adolescents-2/
Lundbeck drug receives EU approval for treatment of schizophrenia in adolescents
赞 (0)
关于作者
Ambu could be heading into a year of billion-kroner acquisitions
上一篇
17 3 月, 2025 1:18 上午
相关推荐
-
Gausium awards SoftBank Robotics America ‘elite certification’
SoftBank Robotics America (SBRA), among the globe’s biggest robotics firms and programmer of commercial cleansing robotics, has actually gotten the highest possible acknowled…
-
Sascha Wolfinger Takes Over Global Communications at Opel
Sascha Wolfinger is currently accountable of international exterior and inner interactions for the Opel and Vauxhall brand names and will certainly likewise come to be a participan…
-
Former FedEx Board Member to Head USPS
The consultation comes with a time of problems that Trump authorities continue to be identified to apply even more control over a company that Congress developed to be independent …
-
Pinecone serverless goes multicloud as vector database market heats up
Pinecone owner isn’t fretted about competitors as vector search and AI end up being table risks in data source market …Read More
-
HIS glitch forces Malaysian hospital to go manual
The break down influenced some 3,000 individuals in a basic healthcare facility.
